Effectiveness of ETI Combination Therapy for N1303K CFTR Variant
投稿者：Unknown
·公開日: 2025-12-13
Discussion regarding the effectiveness of Elexacaftor + Tezacaftor + Ivacaftor (ETI) combination therapy in restoring CFTR function specifically for Cystic Fibrosis patients with the N1303K variant.
読み込み中...